BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23607348)

  • 1. A novel anti-human ICOSL monoclonal antibody that enhances IgG production of B cells.
    Chen J; Wang F; Cai Q; Shen S; Chen Y; Hao C; Sun J
    Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):125-31. PubMed ID: 23607348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity of two novel monoclonal antibodies against human inducible co-stimulator ligand.
    Shen S; Wang F; Chen L; Wang T; Hu Y; Zhang X
    Hybridoma (Larchmt); 2011 Aug; 30(4):361-8. PubMed ID: 21851236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel monoclonal antibody to human inducible co-stimulator ligand (ICOSL): Biological characteristics and application for enzyme-linked immunosorbent assay.
    Hu X; Wu J; An J; Hu Y; Shen Y; Liu C; Zhang X
    Int Immunopharmacol; 2016 Jul; 36():151-157. PubMed ID: 27138044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Novel Functional Monoclonal Antibody to Human CD275: Characterization and Biological Activity.
    Hu X; Liu C; An J; Shen Y; Hu Y; Jiang J; Wu J; Zhang X
    Monoclon Antib Immunodiagn Immunother; 2016 Feb; 35(1):18-24. PubMed ID: 26788906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice.
    Hamel KM; Cao Y; Olalekan SA; Finnegan A
    Arthritis Rheumatol; 2014 Jan; 66(1):60-7. PubMed ID: 24449576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL Therapy.
    Le KS; Thibult ML; Just-Landi S; Pastor S; Gondois-Rey F; Granjeaud S; Broussais F; Bouabdallah R; Colisson R; Caux C; Ménétrier-Caux C; Leroux D; Xerri L; Olive D
    Cancer Res; 2016 Aug; 76(16):4648-60. PubMed ID: 27246829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM10-Mediated ICOS Ligand Shedding on B Cells Is Necessary for Proper T Cell ICOS Regulation and T Follicular Helper Responses.
    Lownik JC; Luker AJ; Damle SR; Cooley LF; El Sayed R; Hutloff A; Pitzalis C; Martin RK; El Shikh MEM; Conrad DH
    J Immunol; 2017 Oct; 199(7):2305-2315. PubMed ID: 28814605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of metalloproteinase ADAM17 in regulating ICOS ligand-mediated humoral immune responses.
    Marczynska J; Ozga A; Wlodarczyk A; Majchrzak-Gorecka M; Kulig P; Banas M; Michalczyk-Wetula D; Majewski P; Hutloff A; Schwarz J; Chalaris A; Scheller J; Rose-John S; Cichy J
    J Immunol; 2014 Sep; 193(6):2753-63. PubMed ID: 25108021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of inducible costimulator ligand (ICOSL) expression in thyroid tissue in hyperthyroidism of Graves' disease patients.
    Wang F; Yan T; Chen L; Chen X; Liu T; Shen S; Li T; Gao L; Wang T; Sun J; Liu C; Wu H; Zhang X; Chen L
    J Clin Immunol; 2012 Dec; 32(6):1253-61. PubMed ID: 22706735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICOS/ICOSL upregulation mediates inflammatory response and endothelial dysfunction in type 2 diabetes mellitus.
    Zhang HY; Ruan LB; Li Y; Yang TR; Liu WJ; Jiang YX; Li TR; Quan J; Xuan W
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8898-8908. PubMed ID: 30575933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis.
    O'Dwyer R; Kovaleva M; Zhang J; Steven J; Cummins E; Luxenberg D; Darmanin-Sheehan A; Carvalho MF; Whitters M; Saunders K; Barelle CJ
    J Immunol Res; 2018; 2018():4089459. PubMed ID: 30417018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of IgG production in a human monoclonal B lymphoblastoid cell line by a B cell-specific monoclonal antibody.
    Miki Y; Kishi H; Muraguchi A; Maruyama S; Kishimoto S; Yamamura Y; Wang CY; Kishimoto T
    J Immunol; 1982 Nov; 129(5):1921-5. PubMed ID: 6981668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help.
    Mayumi M; Kuritani T; Kubagawa H; Cooper MD
    J Immunol; 1983 Feb; 130(2):671-7. PubMed ID: 6217248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B Cell ADAM10 Controls Murine Lupus Progression through Regulation of the ICOS:ICOS Ligand Axis.
    Lownik JC; Wimberly JL; Conrad DH; Martin RK
    J Immunol; 2019 Feb; 202(3):664-674. PubMed ID: 30610163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1F7, a novel cell surface molecule, involved in helper function of CD4 cells.
    Morimoto C; Torimoto Y; Levinson G; Rudd CE; Schrieber M; Dang NH; Letvin NL; Schlossman SF
    J Immunol; 1989 Dec; 143(11):3430-9. PubMed ID: 2479677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new monoclonal anti-human CD83 antibody for flow cytometry, western blot analysis, and ELISA.
    Papp S; Richardt U; Fleischer B; Osterloh A
    Monoclon Antib Immunodiagn Immunother; 2013 Apr; 32(2):98-104. PubMed ID: 23607344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide mediated mast cells induce IL-10 producing regulatory T cells through the ICOSL/ICOS axis.
    Nie X; Cai G; Zhang W; Wang H; Wu B; Li Q; Shen Q
    Clin Immunol; 2012 Mar; 142(3):269-79. PubMed ID: 22154192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.
    Boggio E; Gigliotti CL; Moia R; Scotta A; Crespi I; Boggione P; De Paoli L; Deambrogi C; Garzaro M; Vidali M; Chiocchetti A; Stoppa I; Rolla R; Dianzani C; Monge C; Clemente N; Gaidano G; Dianzani U
    Br J Haematol; 2022 Mar; 196(6):1369-1380. PubMed ID: 34954822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and functional study of five novel monoclonal antibodies against human OX40L highlight reverse signalling: enhancement of IgG production of B cells and promotion of maturation of DCs.
    Wang Q; Chen Y; Ge Y; Sun J; Shi Q; Ju S; Dai J; Yu G; Zhang X
    Tissue Antigens; 2004 Nov; 64(5):566-74. PubMed ID: 15496199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An agonist human ICOS monoclonal antibody that induces T cell activation and inhibits proliferation of a myeloma cell line.
    Deng ZB; Zhu W; Lu CM; Shi Q; Ju SG; Ma HB; Xu Y; Zhang XG
    Hybrid Hybridomics; 2004 Jun; 23(3):176-82. PubMed ID: 15312308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.